Innovative Bioluminescence Technology
Promega has exploited the chemistry of the bioluminescent reaction to create a suite of robust and sensitive biological assays. We offer a number of luminescence output (“Glo”) assays for measuring cell health, cytotoxicity, apoptosis and other cellular events.
Our production team is experienced in the manufacturing and testing of luminescence-based ATP detection and reporter assay reagents. ATP reactions can be tailored for a variety of applications as broad as compound screening, ATP-based microbe testing, and biologic drug discovery and screening. Our bioluminescence platform provides you with many options. Promega luciferase technology is a fundamental platform on which many of our innovative products are built, from the earliest firefly luciferase assays to the Dual-Luciferase® Reporter Assays to the new NanoLuc® Luciferase and substrate. These assays have several advantages:
- Highly sensitive—strong luminescence signal
- Less prone to test compound interference than fluorescent assays
- Amenable to automation and multiplexing with other assay technologies